ROCKET PHARMACEUTICALS, INC. (RCKTW) Shareholders’ equity 2016–2025
ROCKET PHARMACEUTICALS, INC. (RCKTW) shareholders’ equity at each fiscal year-end, per SEC filings.
$277.2MFY2025 · since FY2016: $8.4M → $277.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $277.2M | -40.2% |
| FY2024 | $463.2M | -6.0% |
| FY2023 | $492.6M | +0.6% |
| FY2022 | $489.7M | +7.7% |
| FY2021 | $454.7M | -9.7% |
| FY2020 | $503.5M | +63.9% |
| FY2019 | $307.3M | +58.4% |
| FY2018 | $194.0M | +1150.3% |
| FY2017 | $15.5M | +85.4% |
| FY2016 | $8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice